Comparison of SVEAT and HEART scoring in acute chest pain

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retrospective observational clinical trial assessed MACE prediction in chest pain patients, suggesting SVEAT may outperform HEART scoring.

SVEAT score demonstrated strong predictive performance for MACE with an AUC of 0.988 in chest pain patients.
Primary endpoints included myocardial infarction, PCI, CABG, and sudden cardiac death within 30 days post-evaluation.
The study analyzed data from 557 adult patients, averaging 54.5 years old, showing significant results for the SVEAT score.
Retrospective observational clinical trial methodology highlights the need for further comparative studies on scoring systems.

Yurtseven et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective observational clinical trial assessed MACE prediction in chest pain patients, suggesting SVEAT may outperform HEART scoring.